Search Results - person:"Chen, Kristina"

The effects of forecast type and performance-based incentives on the quality of management forecasts

Chen, Xiaoling; Rennekamp, Kristina M.; Zhou, Flora H. - In: Accounting, organizations and society : an … 46 (2015), pp. 8-18

Persistent link: https://www.econbiz.de/10011420782

Erratum to: Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder

Erder, M.; Xie, Jipan; Signorovitch, James; Chen, Kristina - In: Applied Health Economics and Health Policy 11 (2013) 3, pp. 309-309

Persistent link: https://www.econbiz.de/10010848781

Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison”

Erder, M.; Xie, Jipan; Signorovitch, James; Chen, Kristina - In: Applied Health Economics and Health Policy 11 (2013) 3, pp. 307-307

Persistent link: https://www.econbiz.de/10011000750

Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application of a Matching-Adjusted Indirect Comparison

Haim Erder, M.; Xie, Jipan; Signorovitch, James E.; … - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 381-395

Background:Background: About 7% of children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in the US. Patients with ADHD who are intolerant of or do not have an optimal response to stimulants often use non-stimulants as alternative therapies. Guanfacine...

Persistent link: https://www.econbiz.de/10010585886

Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder

Erder, M.; Xie, Jipan; Signorovitch, James; Chen, Kristina - In: Applied Health Economics and Health Policy 10 (2012) 6, pp. 381-395

<Emphasis Type="Bold">Background: About 7% of children and adolescents are diagnosed with attention-deficit/hyperactivity disorder (ADHD) in the US. Patients with ADHD who are intolerant of or do not have an optimal response to stimulants often use non-stimulants as alternative therapies. Guanfacine extendedrelease...</emphasis>

Persistent link: https://www.econbiz.de/10011000747